[A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].

Source:http://linkedlifedata.com/resource/pubmed/id/8210255

Download in:

View as

General Info

PMID
8210255